| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 435.27M | 299.36M | 227.58M | 179.63M | 82.06M |
| Gross Profit | 388.81M | 260.89M | 199.60M | 154.77M | 69.20M |
| EBITDA | 118.79M | 93.66M | 67.63M | 40.39M | 5.86M |
| Net Income | 45.73M | 40.75M | 16.37M | -8.78M | -26.96M |
Balance Sheet | |||||
| Total Assets | 329.81M | 194.48M | 208.14M | 219.66M | 246.94M |
| Cash, Cash Equivalents and Short-Term Investments | 40.62M | 19.31M | 19.22M | 1.64M | 39.38M |
| Total Debt | 92.39M | 45.55M | 66.38M | 94.44M | 111.97M |
| Total Liabilities | 223.72M | 134.23M | 188.64M | 216.53M | 235.03M |
| Stockholders Equity | 106.09M | 60.25M | 19.50M | 3.13M | 11.91M |
Cash Flow | |||||
| Free Cash Flow | 30.14M | 18.28M | 41.87M | -9.71M | 6.82M |
| Operating Cash Flow | 83.53M | 31.74M | 74.07M | 24.73M | 23.91M |
| Investing Cash Flow | -35.31M | -6.91M | -32.18M | -34.45M | -9.54M |
| Financing Cash Flow | -26.91M | -27.80M | -24.31M | -28.02M | -14.21M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$660.14M | 7.71 | 23.07% | 5.98% | -0.19% | 19.04% | |
68 Neutral | HK$80.00M | -62.59 | -6.37% | 7.50% | -23.23% | -136.17% | |
66 Neutral | HK$5.53B | 21.31 | 70.23% | ― | 56.28% | -9.91% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | HK$280.00M | 44.19 | 11.48% | ― | -20.59% | ― | |
53 Neutral | HK$81.40M | 2.59 | 10.10% | ― | -3.40% | 515.63% | |
48 Neutral | HK$28.82M | -4.31 | -3.96% | ― | 15.60% | 62.35% |